TGFB1 and neoplasm: MDSCs contribute to the immunosuppressive TME by releasing inhibitory molecules such as TGF-β, iNOS, IL-6, Arg1, and IL-10, thereby impairing the tumor-killing capacities of effector T cells and NK cells.